Embelin and Its Derivatives: Design, Synthesis, and Potential Delivery Systems for Cancer Therapy

22Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

Abstract

Embelin is a naturally occurring benzoquinone that inhibits the growth of cancer cells, making it a potent anticancer drug. However, the low water solubility of embelin restricts its clinical applicability. This review provides a concise summary and in-depth analysis of the published literature on the design and synthesis of embelin derivatives possessing increased aqueous solubility and superior therapeutic efficacy. In addition, the potential of drug delivery systems to improve the anticancer capabilities of embelin and its derivatives is discussed.

Cite

CITATION STYLE

APA

Danquah, M. (2022, September 1). Embelin and Its Derivatives: Design, Synthesis, and Potential Delivery Systems for Cancer Therapy. Pharmaceuticals. MDPI. https://doi.org/10.3390/ph15091131

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free